Commonwealth Biotechnologies and bayMountain to develop easy to use genomics portalsRichmond 23 July 2001 Commonwealth Biotechnologies CBTE and bayMountain have signed a letter of intent to develop and commercialise rapid, "user-friendly" methods to help interpret and mine the data present in genome databases. Both companies see an opportunity to combine state-of-the-art computer bioinformatic analyses with DNA sequence determination and protein structure determination.
Bioinformatics encompasses the study of genes and their function. To make sense
of the vast array of information present in the genome of an organism requires
high speed computing technology and management of vast databases. CBI has
developed its own proprietary bioinformatics process that has been successfully
applied to creation of new molecular diagnostic assays for the presence of
individual Herpes viruses.
CBI considers itself a leader in the area of comparative genomics based on its
unique bioinformatic approaches and anticipates that expansion of its computing
capabilities in this area with bayMountain's input will enable it to expand its
client base while facilitating its own discovery efforts. Leading IT analysts
predict significant growth for servers, storage and related IT services in the
bioscience market. Some forecasts indicate that this market will grow from less
than $2.5 billion in 2000 to nearly $12 billion by 2004.
Ad Emmen |
 |